Literature DB >> 3024994

Evaluation of 4-methylpiperidine analogs of hemicholinium-3.

C E Tedford, D Reed, B Bhattacharyya, P Bhalla, J G Cannon, J P Long.   

Abstract

A series of substituted piperidine analogs of hemicholinium-3 was evaluated for their ability to inhibit neuromuscular transmission, to decrease acetylcholine content of caudate slices, to inhibit choline acetyltransferase activity, and to produce toxicity. Quaternary and tertiary amine derivatives of 4-methyl- and 4-hydroxyl-substituted piperidine analogs containing beta-carbonyl or beta-hydroxyl substitutions in the phenylethyl spacing moiety were tested. 4-Methyl piperidine derivatives maintained potent hemicholinium-3 like activity. Reduction of activity was seen with the 4-hydroxyl piperidine analogs. Compounds with beta-hydroxyl substitution were more potent than those with beta-carbonyl substitution. The tertiary amine, 4-methyl piperidine derivative with a hydroxyl group on the beta-carbon of the ethyl side chain also possessed hemicholinium-3 like activity. However, tertiary amine analogs were substantially less potent than hemicholinium-3 or their quaternary amine analogs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024994     DOI: 10.1016/0014-2999(86)90770-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Structure-activity relationship studies of hemicholinium (HC-3) congeners.

Authors:  J G Cannon; T M Lee; Y Chang; A M Nyanda; B Bhattacharyya; J R Flynn; T Chatterjee; R K Bhatnagar; J P Long
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

Review 2.  Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

Authors:  Sean P Arlauckas; Anatoliy V Popov; E James Delikatny
Journal:  Prog Lipid Res       Date:  2016-04-09       Impact factor: 16.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.